Global fragrance creation, development & manufacturing. inquiry@luxeolabs.com
November 17, 2026

Fragrance Allergen Declaration: What Brands Must Put on the Label

How fragrance allergen declaration works in the EU, UK, Canada and the US: thresholds, deadlines, and the supplier data a brand needs to label correctly.

Cosmetic carton showing its ingredient panel

A fragrance allergen declaration is the individual naming, in a cosmetic’s ingredient list, of specific fragrance substances once they pass a set concentration in the finished product. In the EU the threshold is 0.001% for leave-on products and 0.01% for rinse-off products, and since 31 July 2026 the list of covered substances has grown from 26 to more than 80. The label is only as accurate as the data behind it, so the fastest route to compliance is a fragrance developed against your target markets from the first brief. That is how we build custom fragrance oils at Luxeo Labs.

Luxeolabs
luxeolabs.com
Build for Your Target Markets
Luxeo Labs develops tailored fragrance oils with regulatory standards and market trends in mind, helping brands plan labels from the first brief.

Visit

TL;DR

  • Covered fragrance allergens must be listed by name in the ingredient list when they exceed 0.001% in leave-on or 0.01% in rinse-off products, measured in the finished product, not in the fragrance concentrate.
  • The EU expanded the list by 56 substances under Regulation (EU) 2023/1545. New products had to comply from 31 July 2026, and products already on the market can stay available until 31 July 2028.
  • Canada, the UK and the US each run on their own timeline and list, so a single global label is rarely safe.
  • An IFRA certificate is not a legal declaration. You need your supplier’s allergen data and a calculation for each finished formula.
  • Choosing a fragrance partner early, and briefing it with your markets, prevents most relabeling and reformulation work.

Table of Contents

What a fragrance allergen declaration actually is

Cosmetic labels have long allowed a fragrance to appear as a single word: “parfum” or “aroma.” The European Commission confirms that this is still the case. The change is that certain fragrance substances must now also be indicated individually in the ingredient list when they exceed the legal thresholds.

The reason is consumer protection. According to the preamble of the EU regulation, additional allergens identified by the EU’s scientific committee (the SCCS) can pose a potential health risk to some users, so consumers should be told when those substances exceed the specified concentrations. People who are already sensitized to a given substance can then spot it and avoid it.

Two points often surprise new brands:

  • A listing describes chemistry, not danger. The declaration says a substance is present above a threshold. It does not say the product is unsafe.
  • “Fragrance allergen” is a regulatory category, not a statement about where the substance came from. Cosmetic Europe’s guidance notes that the source can be a natural complex substance such as an essential oil, an impurity, or an intentional ingredient. A “natural” fragrance gets no exemption.

Which substances are covered, and how the list changed

Under the earlier EU regime, 24 fragrance allergens were labeled individually. Practitioners often say “the 26 allergens,” because the list is commonly counted that way once grouped entries are split out. Regulation (EU) 2023/1545 then added labeling for 56 additional allergens in Annex III of the EU Cosmetics Regulation and updated existing entries. The Irish regulator HPRA describes the result as more than 80 allergens requiring on-pack disclosure.

Three details matter in practice:

  1. Annex III is the legal text. The Commission’s CosIng database is informative only. When the two seem to differ, Annex III decides.
  2. Prehaptens and prohaptens are treated like allergens. These are substances that turn into known contact allergens through air oxidation or through the skin’s metabolism. The regulation treats them as equivalent to fragrance allergens for the relevant requirements.
  3. Some entries are grouped. Allergens with shared cross-sensitization properties appear under one group name, which keeps ingredient lists readable. For a grouped entry, you add up the concentrations of every substance in the group before comparing the total with the threshold, as the Cosmetic Europe guide explains.

If you have seen “the 14 allergens” mentioned elsewhere, that figure belongs to food allergen labeling, a different regime with a different purpose. It does not apply to cosmetics.

The thresholds, and where they are measured

The EU thresholds are the reference point most other markets copy:

Product type Declare the allergen above
Leave-on (creams, body lotions, fine fragrance, deodorant) 0.001%
Rinse-off (shampoo, shower gel, soap) 0.01%

The European Commission states both figures. The threshold applies to the finished product. A fragrance oil dosed at 0.5% in a lotion carries each allergen at a fraction of its level in the oil, so the same oil can trigger a declaration in one product and not in another.

A worked example

Suppose a leave-on body lotion contains 0.5% of a fragrance oil, and your supplier’s data says the oil contains 0.4% of a given allergen.

  • Allergen in the finished lotion: 0.5% × 0.4% = 0.002%.
  • Leave-on threshold: 0.001%.
  • Result: 0.002% is above 0.001%, so the allergen must be named in the ingredient list.

Put the same oil in a rinse-off shower gel at 0.5% and the result is still 0.002%, which is below the 0.01% rinse-off threshold. No individual declaration is needed there. One fragrance, two products, two different labels. The calculation is why a brand with a range needs a per-formula check rather than a per-fragrance one.

Deadlines: what applies now

The transition dates in the EU were set by the regulation itself, with a three-year period before the expanded provisions apply to new products and a five-year period for withdrawing legacy products. In practice:

  • From 31 July 2026: products that do not comply may no longer be placed on the EU market, per the European Commission.
  • Until 31 July 2028: products placed on the market before that date may continue to be made available.

If you are launching a new SKU in the EU today, it needs the expanded declaration. If you are relabeling a legacy range, the 2028 date is your hard stop for stock that was placed on the market earlier.

Market by market

Because your reader’s brand may sell worldwide, here is how the main markets compare. Treat each date as a starting point and confirm it with the regulator before printing.

Market Where it stands
EU Expanded list applies to new products since 31 July 2026; legacy stock may remain available until 31 July 2028.
UK A 2026 global guide from SGS reports that the UK continues to apply its inherited 24-allergen framework and had not adopted the EU’s expanded list as of 18 August 2026.
Canada Health Canada’s amendment SOR/2024-63 introduced EU-aligned disclosure. The same SGS guide gives staged dates of 12 April 2026 for the existing list, 1 August 2026 for the expanded list on new products and 1 August 2028 for the expanded list on all products.
US Federal law now requires fragrance allergens to be identified on cosmetic labels, but the list and rules depend on an FDA rulemaking. See below.

For a deeper look at the British position, our guide to fragrance regulations in the UK covers it for brands and manufacturers.

The US position

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added section 609(b) to the Federal Food, Drug, and Cosmetic Act. According to the federal regulatory agenda entry for the FDA rule, that section requires each fragrance allergen in a cosmetic to be identified on its label, and the FDA is tasked with proposing which substances count as fragrance allergens and how they are disclosed. Until the FDA’s final rule sets the list and thresholds, US brands that also sell in the EU or Canada commonly build to the stricter EU-style approach so one formula and one label can travel. Check the FDA’s rulemaking page for its current status before you finalize US artwork.

How the declaration appears on the label

The individual allergen is written in the ingredient list using its INCI name (the standard international ingredient naming system), alongside the general “parfum” or “aroma” entry. The allergen is listed in the ingredient order that matches its concentration in the product, so it does not appear at the end by default. Because the rules for grouped entries and for ingredients that can come from several sources are detailed, the Annex III text and the Cosmetic Europe guidance should be read together by whoever signs off the label.

How fragrance allergens appear in ingredient lists

One point of confusion is claims. A product marketed as “fragrance-free” or “unscented” follows different logic from a product that simply has no declarable allergens. Our article on fragrance-free versus unscented explains the difference for brands. Likewise, reading the full ingredient list is how consumers decode any marketing claim, a theme explored in this piece on what a label claim really means.

Compliance steps for a brand

Here is the routine that works for a finished product, with the places it usually goes wrong.

  1. List your target markets and product types. Each market has its own list and dates, and leave-on versus rinse-off changes the threshold. The common error is assuming one label fits all.
  2. Get full allergen data from your fragrance supplier. Cosmetic Europe’s guide says the responsible person should calculate allergen concentration in the finished cosmetic using supplier information such as an IFRA information-exchange document. Data that covers only the old 26 substances is no longer enough for the EU.
  3. Calculate per formula. Multiply fragrance dosage by each allergen’s level in the oil, and sum grouped entries. Redo the calculation whenever you change dosage, fragrance or base.
  4. Include allergens from other sources. Essential oils, botanical extracts and impurities in other ingredients can contribute to the same substance. The regulation does not care whether it arrived through the perfume or elsewhere.
  5. Write the declaration into the ingredient list and proof the artwork. Check the INCI names against Annex III.
  6. Keep the documentation. Retain the supplier data and calculations in the product information file that the EU requires the responsible person to maintain.
  7. Re-check when rules move. The EU, Canada and the US have all changed or are changing their requirements, so build a review date into your regulatory calendar.

A step that trips up many first-time brands is step 2: requesting data at the end of development, after the formula is locked. A fragrance chosen on scent alone can push you over a threshold, and fixing it then means reformulating or changing the label.

IFRA, the International Fragrance Association, publishes standards that restrict or prohibit certain fragrance materials. They are valuable, but the IFRA regulatory FAQ states that fragrance manufacturers must comply with the regulations of the countries where they operate and market products, and that IFRA Standards are a separate, voluntary risk-management system which may differ from legal requirements. A certificate tells you a fragrance meets IFRA’s safety limits for a use category. It does not tell you what has to appear on your label in a given country. For a plain-language overview of how those standards relate to skin contact, see our guide on whether fragrance oils are safe for skin.

IFRA is not the same as legal compliance

Designing the allergen question out of the brief

Most brands treat the declaration as a printing task at the end. It is cheaper to treat it as a design input at the start. If your product is a leave-on item for sensitive skin, you can brief the perfumer to keep the allergen load low. If your product is a rinse-off item, you have more room, and a different threshold applies. Our related guide on fragrance for sensitive skin shows how that brief changes the scent choices.

Two choices shape the outcome more than any other:

  • Dosage. A lower fragrance dose in the finished product lowers every allergen’s concentration proportionally.
  • Raw material strategy. Whether a scent is built from complex natural materials or from isolated components changes which allergens are present and how predictable the data is. We compare the two approaches in fragrance oil versus aroma chemicals.

Our perspective

We see the allergen declaration as a development question that happens to end up on a label. By the time artwork is being proofed, the choices that decide what must be declared were made months earlier, in the brief and the formula.

That is why we work the way we do. Luxeo Labs develops custom fragrance oils for fine fragrance, personal care, home care and fabric care, with in-house perfumery and scientific teams and facilities in Grasse, Sharjah and Mumbai. Our development approach is built around regulatory standards and market requirements, and we aim to move from brief to market-ready product faster, so that compliance is part of the work rather than a late audit.

Our advice to brands is simple: name your markets in the first conversation, tell your fragrance partner the product type and dosage, and treat each finished formula as its own compliance question. A brand that does this launches with fewer surprises, and fewer labels to reprint.

Subscriptions

Work with a fragrance partner who builds for your markets

If you are developing a new scent, or reformulating a range ahead of the 2028 EU deadline, we can build the fragrance around your target markets from the brief. Our tailored fragrance development service covers fine fragrances, personal care, home and air care, and laundry care, and our bulk production and private label capability scales the approved formula.

Luxeolabs

Tell us the markets, the product types and the dosage you have in mind, and we will shape the brief from there. Start at luxeolabs.com.

FAQ

What are fragrance allergens in cosmetics?

They are fragrance substances that the EU’s scientific committee has identified as potential contact allergens for some people. When one of them exceeds the legal threshold in a finished product, it must be named in the ingredient list in addition to “parfum” or “aroma.” The listing identifies a substance. It does not mean the product is unsafe for everyone.

How many fragrance allergens must be declared in the EU?

The earlier EU rules covered 24 individually labeled allergens, often quoted as 26 once grouped entries are counted. Regulation (EU) 2023/1545 added 56 more, so the Irish regulator describes the total as more than 80. Annex III of the EU Cosmetics Regulation is the legally binding list.

Does a product sold in the US need an allergen declaration?

US law (MoCRA section 609(b)) requires fragrance allergens to be identified on cosmetic labels, with the FDA responsible for defining the covered substances and the disclosure format through rulemaking. Check the FDA’s rule status before finalizing artwork. Brands that also sell in the EU or Canada often apply the EU thresholds across their range.

Can I rely on my supplier’s IFRA certificate for labeling?

No. IFRA Standards are voluntary risk-management rules and may differ from legal requirements. For the label, you need the supplier’s allergen composition data and a calculation of each allergen’s concentration in your finished product.

Do I have to relabel products already on the EU market?

Products placed on the EU market before 31 July 2026 may continue to be made available until 31 July 2028. Anything placed on the market after the first date must carry the expanded declaration.

Sources

From insight to application

Ready to create a fragrance with purpose?

Talk to Luxeo about your product, market, and sensory direction.

Start your brief